Xiao-qing Liu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Phase I/II Study of Tifcemalimab, an Anti-B- and T-lymphocyte Attenuator Antibody, in Combination with Toripalimab in Previously Treated Advanced Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 03, 2025
Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II study.
Journal: Cancer immunology, immunotherapy : CII
Published: July 19, 2021
A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non-Small Cell Lung Cancer: a Multicenter Phase I/II Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 16, 2021
The Chinese Thoracic Oncology Group (CTONG) therapeutic option scoring system: a multiple-parameter framework to assess the value of lung cancer treatment options.
Journal: Translational lung cancer research
Published: May 08, 2021
A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancer.
Journal: Investigational new drugs
Published: August 13, 2020
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma.
Journal: Frontiers in oncology
Published: January 21, 2020
A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel.
Journal: Translational lung cancer research
Published: July 28, 2018
A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel.
Journal: ESMO open
Published: February 01, 2017
Circulating microRNAs as novel biomarkers of ALK-positive nonsmall cell lung cancer and predictors of response to crizotinib therapy.
Journal: Oncotarget
Published: January 26, 2017
Serum peptide expression and treatment responses in patients with advanced non-small-cell lung cancer.
Journal: Oncology letters
Published: September 19, 2016
Circulating tumor cell counts/change for outcome prediction in patients with extensive-stage small-cell lung cancer.
Journal: Future oncology (London, England)
Published: February 04, 2016
Combination of icotinib, surgery, and internal-radiotherapy of a patient with lung cancer severely metastasized to the vertebrae bones with EGFR mutation: a case report.
Journal: OncoTargets and therapy
Published: June 18, 2015
Last Updated: 09/26/2026